NCT03307109 Quality of Life in Patients Having a Prosthetic Joint Infection
| NCT ID | NCT03307109 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Quality of Life |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2017-10-17 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2017-10-17 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bone and joint infections (BJI) are rare serious pathology which can lead to a very heavy handicap and sometimes to the life threatening. These are devastating diseases whose diagnosis is difficult. They are known to be associated with high mortality rates (5%) and significant morbidities responsible for functional sequelae (40% of patients) with an individual cost (prolonged hospitalization, altered quality of life) and societal (work stoppage, partial or total disability, temporary or permanent) extremely high. These bone and joint infections have a significant impact on the quality of life of those affected who, in addition to their infection, are reduced in their autonomy and often need to be taken care of outside their home, sometimes away from home. To the knowledge of investigators, there are few studies on the measurement of quality of life in patients with osteoarticular infection. The aim of this study is to implement the EQ-5D-3L validated quality of life questionnaire and the EVA scale (created by EuroQol Group) for each patient with a prosthetic joint infection (IPA) on prosthesis during their medical care in the department of Infectious and Tropical Diseases.
Eligibility Criteria
Inclusion Criteria: * Patient having prosthetic joint infection * Patient who did not object to participate in the study * Patients over 18 years of age Exclusion Criteria: * Patient with additional psychological or psychiatric support outside the service. * Patient benefiting from a system of legal protection (safeguard of justice, guardianship, curatorship) * Patient participating in another study on measuring quality of life * Patients with cognitive impairment to understand the questionnaire * Impossibility of giving the patient informed information * Patients with no infection diseases follow up at the CROIX ROUSSE hospital * Patients with amputation as initial surgery for infection management
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03307109 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03307109 currently recruiting?
Yes, NCT03307109 is actively recruiting participants. Contact the research team at tristan.ferry@chu-lyon.fr for enrollment information.
Where is the NCT03307109 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT03307109 clinical trial?
NCT03307109 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 250 participants.